CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Realcan Pharmaceutical Group Co Ltd Company Snapshot
Realcan Pharmaceutical Group Co Ltd operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Realcan Pharmaceutical Group Co Ltd with three other companies in this sector in China: Zhejiang International Group Company Limited (2017 sales of 18.91 billion Chinese Renmimbi [US$2.80 billion] of which 100% was Medicine Retailing), C.Q. Pharmaceutical Holding Co Ltd (23.04 billion Chinese Renmimbi [US$3.41 billion] of which 92% was Drug Sales), and Yunnan Baiyao Group Co., Ltd. (24.31 billion Chinese Renmimbi [US$3.60 billion] of which 59% was Comodities Trading).

Sales Analysis. Realcan Pharmaceutical Group Co Ltd reported sales of 23.29 billion Chinese Renmimbi (US$3.45 billion) for the year ending December of 2017. This represents an increase of 49.1% versus 2016, when the company's sales were 15.62 billion Chinese Renmimbi. Sales at Realcan Pharmaceutical Group Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 404%). Sales of Medical Services saw an increase of 67.2% in 2017, from 19.68 million Chinese Renmimbi to 32.92 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Realcan Pharmaceutical Group Co Ltd
  Stock Performance Chart for Realcan Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 6.95
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 4.4%  
4 Weeks -26.7%   52 Weeks -47.8%  
 
Realcan Pharmaceutical Group Co Ltd Key Data:
  Ticker: 002589 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 23,293,620,460
(Year Ending Jan 2018).
Employees: 6,914
  Currency: Chinese Renmimbi Market Cap: 10,457,737,773
  Fiscal Yr Ends: December Shares Outstanding: 1,504,710,471
  Share Type: Class A Closely Held Shares: 644,125,386
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.